tiprankstipranks
Trending News
More News >
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market

Dianthus Therapeutics (DNTH) Income Statement

Compare
422 Followers

Dianthus Therapeutics Income Statement

Last quarter (Q4 2025), Dianthus Therapeutics's total revenue was $284.00K, a decrease of -78.58% from the same quarter last year. In Q4, Dianthus Therapeutics's net income was $97.91M. See Dianthus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.04M$ 6.24M$ 2.83M$ 6.42M$ 1.48M
Gross Profit
$ 2.04M$ 6.24M$ 2.83M$ 6.42M$ 1.48M
Operating Expenses
$ 179.97M$ 108.10M$ 51.00M$ 36.12M$ 14.56M
Depreciation and Amortization
$ 0.00$ 412.00K$ 355.00K$ 147.00K$ 0.00
EBITDA
$ -177.93M$ -101.45M$ -47.82M$ -29.56M$ -13.09M
Operating Income
$ -177.93M$ -101.86M$ -48.17M$ -29.70M$ -13.09M
Other Income/Expenses
$ 15.60M$ 16.89M$ 4.62M$ 1.23M$ -23.00K
Pretax Income
$ -162.34M$ -84.97M$ -43.55M$ -28.48M$ -13.11M
Net Income
$ -162.34M$ -84.97M$ -43.55M$ -28.48M$ -13.11M
Per Share Metrics
Basic EPS
$ -4.20$ -2.55$ -8.45$ -7.60$ -3.82
Diluted EPS
$ -4.20$ -2.55$ -8.45$ -7.60$ -3.82
Weighted Average Shares Outstanding
37.79M 33.31M 5.15M 3.75M 3.43M
Weighted Average Shares Outstanding (Diluted)
37.79M 33.31M 5.15M 3.75M 3.43M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History